Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.3%

62 terminated/withdrawn out of 1175 trials

Success Rate

91.9%

+5.3% vs industry average

Late-Stage Pipeline

11%

131 trials in Phase 3/4

Results Transparency

12%

85 of 702 completed trials have results

Key Signals

121 recruiting85 with results47 terminated15 withdrawn

Enrollment Performance

Analytics

N/A

400(47.2%)

Phase 1

193(22.8%)

Phase 2

106(12.5%)

Phase 4

71(8.4%)

Phase 3

60(7.1%)

Early Phase 1

17(2.0%)

847Total

N/A(400)

Phase 1(193)

Phase 2(106)

Phase 4(71)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1175)

Showing 20 of 1175 trials

NCT05169333Recruiting

The Oxford Risk Factors And Non-Invasive Imaging Study

Role: lead

NCT04704999Phase 4Recruiting

Southeast Asia Dose Optimization of Tafenoquine

Role: lead

NCT07731971Not Yet Recruiting

Digital Outcome Assessment Using AI Active Gaming and Motion Capture in Friedreich Ataxia

Role: collaborator

NCT07470320Recruiting

Placental Biology in Health and Disease

Role: lead

NCT06821282Recruiting

Surveillance of AMR in DRC

Role: lead

NCT07215195Recruiting

Neuropsychiatric Outcomes and Disrupted Sleep Following Acquired Brain Injury

Role: lead

NCT05887271Phase 2Completed

A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction

Role: collaborator

NCT05978037Phase 1Completed

A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines

Role: lead

NCT04943588Completed

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

Role: collaborator

NCT07397455Phase 1Recruiting

Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants

Role: collaborator

NCT07694076Not ApplicableRecruiting

Repeated Real-time Biofeedback With 7-Tesla MRI for Treatment of Depression

Role: lead

NCT07692295Not Yet Recruiting

Biomarkers for Post-treatment Control in HIV: International Study of the EU2Cure Research Consortium (Phase I)

Role: collaborator

NCT04083508Not ApplicableCompleted

Vivax Malaria Human Infection Studies in Thailand

Role: lead

NCT07054931Phase 2Recruiting

Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV

Role: lead

NCT04936620Not ApplicableRecruiting

Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

Role: collaborator

NCT07643818Phase 2Enrolling By Invitation

Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency

Role: collaborator

NCT07139093Not ApplicableCompleted

Testing of an Interface for Synchronizing tACS-DBS With a Phase-locked-loop

Role: collaborator

NCT05535868Not ApplicableCompleted

Experimental Human Pneumococcal Challenge With SPN3

Role: collaborator

NCT05441267Phase 4Active Not Recruiting

A Study of Cardiovascular Events iN Diabetes Plus

Role: lead

NCT03531073Completed

Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis

Role: lead